R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

Junji Ichikawa, Toshihide Kuroki, Michael T. Kitchen, Herbert Y. Meltzer

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Systemic administration of R(+)-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin), a selective serotonin (5-hydroxytryptamine, 5-HT)1A receptor agonist (25, 50, and 100 μg/kg s.c.), administered 30 min prior to d-amphetamine, significantly inhibited the d-amphetamine sulfate (1.0 mg/kg s.c.)-induced increase in extracellular dopamine levels in the striatum and nucleus accumbens of freely moving rats, as determined by in vivo microdialysis. The ability of R(+)-8-OH-DPAT (50 μg/kg s.c.) to inhibit d-amphetamine sulfate (1.0 mg/kg s.c.)-induced increase in extracellular dopamine levels was abolished by WAY 100,635 (n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride), a selective 5-HT1A receptor antagonist (100 μg/kg s.c.), administered 5 min prior to R(+)-8-OH-DPAT in both regions. These results indicate that the 5-HT1A receptor may exert an inhibitory effect on amphetamine-induced dopamine release.

Original languageEnglish
Pages (from-to)179-184
Number of pages6
JournalEuropean Journal of Pharmacology
Volume287
Issue number2
DOIs
Publication statusPublished - Dec 12 1995
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint Dive into the research topics of 'R(+)-8-OH-DPAT, a 5-HT<sub>1A</sub> receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens'. Together they form a unique fingerprint.

  • Cite this